News|Articles|October 2, 2004
- Pharmaceutical Technology-10-02-2004
- Volume 28
- Issue 10
Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up
Author(s)Jim Miller
Big Pharma is ramping up capital spending in parenteral manufacturing at the same time that contract manufacturers are completing their own major investment programs.
Advertisement
Articles in this issue
about 21 years ago
A Novel Freeze Pelletization Technique for Preparing Matix Pelletsabout 21 years ago
Aseptic Processing: A Review of Current Industry Practiceabout 21 years ago
Can Inserts Be Improved?about 21 years ago
Drug Development Linked More Closely to Diagnosticsabout 21 years ago
In The Spotlight-October 2004about 21 years ago
October 2004about 21 years ago
The High Price of SuccessNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
4
Turning Real-World Data into Actionable Drug Development Insights With AI
5
